AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26053149 — intervention group
Group type: EXPERIMENTAL
Intervention: Children's learning-related behaviors in kindergarten
Number of subjects: 239
Study 23098414 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental multilevel intervention designed to improve quality of care and resident outcomes
Number of subjects: 29
Study 23098414 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental multilevel intervention
Number of subjects: 29
Study 21725875 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture (EA)
Number of subjects: 63
Study 21725875 — intervention group
Group type: COMPARATOR
Intervention: Simple needling (SN)
Number of subjects: 63
Study 19526433 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) acupuncture
Number of subjects: 89
Study 19526433 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 89
Study 19526433 — intervention group
Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 89
Study 16478842 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV biofeedback
Number of subjects: 45
Study 16478842 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV biofeedback with additional training in pursed-lips abdominal breathing
Number of subjects: 45
Study 15457926 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus casei DN114001 fermented milk (10(8)-10(10) ufc/g), 3 cups per day for 8 weeks
Number of subjects: 45
Study 15457926 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 3 cups per day for 8 weeks
Number of subjects: 45
Study 11679027 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine plus Passiflora extract
Number of subjects: 65
Study 11679027 — intervention group
Group type: COMPARATOR
Intervention: Clonidine plus placebo
Number of subjects: 65
Study 9777137 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirudin treatment in patients with ST elevation receiving thrombolytic therapy (TIMI 9)
Number of subjects: 15000
Study 9777137 — intervention group
Group type: EXPERIMENTAL
Intervention: Hirudin treatment in the full spectrum of acute coronary syndromes (GUSTO 2)
Number of subjects: 15000
Study 7932515 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 400 micrograms oral dose
Number of subjects: 15
Study 7932515 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2892768 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizatidine (300 mg 'nocte')
Number of subjects: 165
Study 2892768 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine (300 mg 'nocte')
Number of subjects: 165
Study 29345532 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic Preconditioning (IPC) - 3×5-min occlusions with 5-min reperfusion, 15 min prior to sprinting
Number of subjects: 18
Study 29345532 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo (SHAM) - 15 min prior to sprinting
Number of subjects: 18
Study 29345532 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 18
Study 27302544 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive-behavioural therapy
Number of subjects: 397
Study 27302544 — intervention group
Group type: COMPARATOR
Intervention: Routine postpartum care
Number of subjects: 397
Study 24145571 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical basic fibroblast growth factor plus oral L‐cysteine supplements (Group 1)
Number of subjects: 120
Study 24145571 — intervention group
Group type: COMPARATOR
Intervention: Basic fibroblast growth factor eye drops (Group 2)
Number of subjects: 120
Study 22978615 — intervention group
Group type: EXPERIMENTAL
Intervention: Diamel (two capsules before each of the three main meals daily for 1 year)
Number of subjects: 100
Study 22978615 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two capsules before each of the three main meals daily for 1 year)
Number of subjects: 100
Study 19789920 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen (LN) fundoplication
Number of subjects: 100
Study 19789920 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Toupet (LT) fundoplication
Number of subjects: 100
Study 18387407 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneas from donors <66.0 years
Number of subjects: 1090
Study 18387407 — intervention group
Group type: COMPARATOR
Intervention: Corneas from donors ≥66.0 years
Number of subjects: 1090
Study 11905457 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum therapy at presentation plus maximum therapy at local relapse
Number of subjects: 0
Study 11905457 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study 9654538 — intervention group
Group type: EXPERIMENTAL
Intervention: Enoxaparin (40 mg once daily, subcutaneously for not less than seven days)
Number of subjects: 307
Study 9654538 — intervention group
Group type: COMPARATOR
Intervention: Compression stockings alone (placebo)
Number of subjects: 307
Study 8077067 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (early intervention trial)
Number of subjects: 1395
Study 2572136 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 70
Study 2572136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 189385 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline 0.25 mg
Number of subjects: 10
Study 189385 — intervention group
Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 10
Study 28219437 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified software with basic shortcut menu changes and evidence-based decision support based on USPSTF recommendations
Number of subjects: 0
Study 28219437 — intervention group
Group type: COMPARATOR
Intervention: Usual software (control group)
Number of subjects: 0
Study 28219437 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified software
Number of subjects: 0
Study 26665978 — intervention group
Group type: EXPERIMENTAL
Intervention: EOB body cream
Number of subjects: 29
Study 23546045 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole plus pemetrexed
Number of subjects: 23
Study 23546045 — intervention group
Group type: COMPARATOR
Intervention: Pemetrexed alone (Control)
Number of subjects: 23
Study 21807659 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g dark chocolate (>85% cocoa)
Number of subjects: 40
Study 21807659 — intervention group
Group type: COMPARATOR
Intervention: 40 g milk chocolate (≤35% cocoa)
Number of subjects: 40
Study 19494810 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (20‐80 mg) before and after gastric bypass surgery
Number of subjects: 12
Study 16441926 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-casein A1
Number of subjects: 15
Study 16441926 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-casein A2
Number of subjects: 15
Study 14720197 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic capsaicin 0.25%
Number of subjects: 50
Study 14720197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 11387176 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic milk with Lactobacillus GG
Number of subjects: 571
Study 11387176 — intervention group
Group type: COMPARATOR
Intervention: Placebo milk without Lactobacillus GG
Number of subjects: 571
Study 9408067 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg per day
Number of subjects: 46
Study 9408067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study 8270392 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of cefuroxime (1.5 g i.v. on call to surgery)
Number of subjects: 100
Study 8270392 — intervention group
Group type: COMPARATOR
Intervention: Triple dose of cefuroxime (1.5 g i.v. on call to surgery followed by two additional doses of 750 mg i.v. each, 8 and 16 h after surgery)
Number of subjects: 100
Study 29493058 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 1195
Study 29493058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1195
Study 27513476 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental monitoring
Number of subjects: 257
Study 27513476 — intervention group
Group type: COMPARATOR
Intervention: Parental distress
Number of subjects: 257
Study 27513476 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental self-efficacy
Number of subjects: 257
Study 27513476 — intervention group
Group type: EXPERIMENTAL
Intervention: Authoritative parenting
Number of subjects: 257
Study 25102877 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin continuation (100mg/d)
Number of subjects: 90
Study 25102877 — intervention group
Group type: COMPARATOR
Intervention: Aspirin withdrawal 3 days pre-extraction
Number of subjects: 90
Study 25102877 — intervention group
Group type: COMPARATOR
Intervention: Aspirin withdrawal 5 days pre-extraction
Number of subjects: 90
Study 22018760 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir (all doses combined)
Number of subjects: 205
Study 22018760 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz
Number of subjects: 205
Study 22018760 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 205
Study 19818562 — intervention group
Group type: EXPERIMENTAL
Intervention: Overcommitment (OC)
Number of subjects: 200
Study 19818562 — intervention group
Group type: COMPARATOR
Intervention: Depressive symptoms and work stress scores
Number of subjects: 200
Study 19818562 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone/CRH test
Number of subjects: 200
Study 18451744 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS)
Number of subjects: 15
Study 16442037 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A
Number of subjects: 77
Study 16442037 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 77
Study 16442037 — intervention group
Group type: EXPERIMENTAL
Intervention: StriVectin‐SD
Number of subjects: 77
Study 16442037 — intervention group
Group type: EXPERIMENTAL
Intervention: DDF Wrinkle Relax
Number of subjects: 77
Study 16442037 — intervention group
Group type: EXPERIMENTAL
Intervention: HydroDerm
Number of subjects: 77
Study 14504114 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mL of an antacid suspension 4 times daily
Number of subjects: 82
Study 14504114 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of colloidal bismuth subcitrate 4 times daily
Number of subjects: 82
Study 14504114 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of famotidine twice daily
Number of subjects: 82
Study 14504114 — intervention group
Group type: COMPARATOR
Intervention: Placebo twice daily
Number of subjects: 82
Study 10624993 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ketamine 0.15 mg/kg after induction and normal saline at the end of surgery (PRE group)
Number of subjects: 45
Study 10624993 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ketamine at the end of surgery (POST group)
Number of subjects: 45
Study 10624993 — intervention group
Group type: COMPARATOR
Intervention: Normal saline at the beginning and end of surgery (CONT group)
Number of subjects: 45
Study 9098871 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% betamethasone 17-valerate cream formulation
Number of subjects: 0
Study 9098871 — intervention group
Group type: EXPERIMENTAL
Intervention: Chromameter assessment
Number of subjects: 0
Study 8471654 — intervention group
Group type: EXPERIMENTAL
Intervention: Weighted feeding tubes
Number of subjects: 70
Study 8471654 — intervention group
Group type: COMPARATOR
Intervention: Unweighted feeding tubes
Number of subjects: 70
Study 3954175 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraclavicular approach
Number of subjects: 500
Study 3954175 — intervention group
Group type: COMPARATOR
Intervention: Infraclavicular approach
Number of subjects: 500
Study 3954175 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate approach after failure
Number of subjects: 500
Study 31743365 — intervention group
Group type: EXPERIMENTAL
Intervention: 18-month web-based lifestyle modification intervention
Number of subjects: 216
Study 31743365 — intervention group
Group type: EXPERIMENTAL
Intervention: ≥ 10% weight loss
Number of subjects: 216
Study 29490538 — intervention group
Group type: EXPERIMENTAL
Intervention: Friendly VPs
Number of subjects: 46
Study 29490538 — intervention group
Group type: EXPERIMENTAL
Intervention: Disruptive VPs
Number of subjects: 46
Study 29490538 — intervention group
Group type: COMPARATOR
Intervention: No patient story VPs
Number of subjects: 46
Study 27372742 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (CAF, 6 mg kg(‐1))
Number of subjects: 15
Study 27372742 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 15
Study 24116922 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-month intervention based on the Information-Motivation-Behavioral Skills (IMB) model
Number of subjects: 100
Study 24116922 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 23327027 — intervention group
Group type: EXPERIMENTAL
Intervention: parecoxib 40 mg twice daily
Number of subjects: 120
Study 23327027 — intervention group
Group type: EXPERIMENTAL
Intervention: metamizol 1 g three times daily
Number of subjects: 120
Study 23327027 — intervention group
Group type: EXPERIMENTAL
Intervention: paracetamol 1 g three times daily
Number of subjects: 120
Study 23327027 — intervention group
Group type: COMPARATOR
Intervention: normal saline (NaCl)
Number of subjects: 120
Study 20558830 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive motor training program (n=30) with 3 sessions of physical therapy and a structured home exercise program for 4 weeks after discharge.
Number of subjects: 62
Study 20558830 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment group (n=32).
Number of subjects: 62
Study 20558830 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive motor training group (n=30).
Number of subjects: 62
Study 17917468 — intervention group
Group type: EXPERIMENTAL
Intervention: Zen meditation (MED)
Number of subjects: 124
Study 17917468 — intervention group
Group type: COMPARATOR
Intervention: no meditation (noMED)
Number of subjects: 124
Study 16202862 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flavonoid (HF) sweetie juice
Number of subjects: 12
Study 16202862 — intervention group
Group type: COMPARATOR
Intervention: Low-flavonoid (LF) sweetie juice
Number of subjects: 12
Study 12134377 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 0
Study 12134377 — intervention group
Group type: COMPARATOR
Intervention: No guided imagery (control group)
Number of subjects: 0
Study 10430197 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin tocolysis (50 mg followed by 25 mg 6 hourly for 48 hours)
Number of subjects: 34
Study 10430197 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 10430197 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 34
Study 7582391 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebhydroline (Omeril) 100 mg t.i.d.
Number of subjects: 34
Study 7582391 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 2221579 — intervention group
Group type: EXPERIMENTAL
Intervention: NO2 exposure (2-ppm peaks with 0.05 ppm background for 3 hours)
Number of subjects: 24
Study 2221579 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous exposure to 1.5 ppm NO2 for 3 hours
Number of subjects: 24
Study 2221579 — intervention group
Group type: COMPARATOR
Intervention: Air exposure (control)
Number of subjects: 24
Study 532631 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (low carbohydrate)
Number of subjects: 104
Study 532631 — intervention group
Group type: COMPARATOR
Intervention: Hypocaloric diet
Number of subjects: 104
Study 31182047 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured skills training group (SSTG) based on dialectical behaviour therapy (DBT)
Number of subjects: 184
Study 31182047 — intervention group
Group type: COMPARATOR
Intervention: Active control group based on psychoeducation
Number of subjects: 184
Study 27676603 — intervention group
Group type: EXPERIMENTAL
Intervention: Early fortification from the first feeding
Number of subjects: 80
Study 27676603 — intervention group
Group type: COMPARATOR
Intervention: Late fortification
Number of subjects: 80
Study 25704463 — intervention group
Group type: COMPARATOR
Intervention: Spherical off-the-shelf contact lenses (SL)
Number of subjects: 23
Study 25704463 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom toric contact lenses (TL)
Number of subjects: 23
Study 25704463 — intervention group
Group type: COMPARATOR
Intervention: Spectacles
Number of subjects: 23
Study 23843099 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 110 mg
Number of subjects: 4904
Study 23843099 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg
Number of subjects: 4904
Study 23843099 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 4904
Study 21606131 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 2000 mg/day
Number of subjects: 150
Study 21606131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study 19623081 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term psychotherapy (STP)
Number of subjects: 100
Study 19623081 — intervention group
Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 100
Study 17236959 — intervention group
Group type: EXPERIMENTAL
Intervention: Pd-103 and supplemental beam radiation
Number of subjects: 179
Study 12817827 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 g/day ethanol
Number of subjects: 14
Study 12817827 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 g/day ethanol
Number of subjects: 14
Study 12817827 — intervention group
Group type: COMPARATOR
Intervention: 0 g/day ethanol
Number of subjects: 14
Study 10836489 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 microg CCK‐4
Number of subjects: 40
Study 10836489 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 9277075 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (1.0‐2.5 mg/kg for induction, continuous infusion of 2‐12 mg/kg/h) with fentanyl (50 micrograms) and vecuronium (0.08 mg/kg for intubation)
Number of subjects: 60
Study 9277075 — intervention group
Group type: COMPARATOR
Intervention: Isoflurane with thiopental (3‐5 mg/kg for induction), succinylcholine (1‐2 mg/kg for intubation), and vecuronium as a muscle relaxant
Number of subjects: 60
Study 8243428 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fibre diet (experimental group)
Number of subjects: 12
Study 8243428 — intervention group
Group type: COMPARATOR
Intervention: Regular high-fibre diet (control group)
Number of subjects: 12
Study 3533676 — intervention group
Group type: COMPARATOR
Intervention: 25 mg trazodone tds
Number of subjects: 20
Study 3533676 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg trazodone tds
Number of subjects: 20
Study 3533676 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg total daily trazodone
Number of subjects: 20
Study 30954312 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision aid intervention
Number of subjects: 140
Study 30954312 — intervention group
Group type: COMPARATOR
Intervention: Control questionnaire
Number of subjects: 140
Study 27776458 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise program conducted three times a week for 6 weeks
Number of subjects: 20
Study 27776458 — intervention group
Group type: COMPARATOR
Intervention: Control group (recommended sports brassiere, refraining from caffeine and methylxanthine-containing foods, and simple analgesics)
Number of subjects: 20
Study 26371358 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum weight management program
Number of subjects: 0
Study 26371358 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 23287080 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan 0.1 μg/kg/min
Number of subjects: 60
Study 23287080 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine 5 μg/kg/min
Number of subjects: 60
Study 22321495 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser Peripheral Iridotomy (LPI)
Number of subjects: 60
Study 22321495 — intervention group
Group type: COMPARATOR
Intervention: Surgery Peripheral Iridectomy (SPI)
Number of subjects: 60
Study 19841759 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine solution
Number of subjects: 100
Study 19841759 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5% NaOCl
Number of subjects: 100
Study 19841759 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% chlorhexidine gel
Number of subjects: 100
Study 19841759 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% H2O2
Number of subjects: 100
Study 19841759 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 100
Study 16908915 — intervention group
Group type: EXPERIMENTAL
Intervention: Revised 4-variable MDRD Study equation
Number of subjects: 1628
Study 16908915 — intervention group
Group type: COMPARATOR
Intervention: Original 6-variable MDRD Study equation
Number of subjects: 1628
Study 16908915 — intervention group
Group type: COMPARATOR
Intervention: Cockcroft-Gault equation
Number of subjects: 1628
Study 15680101 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniportal endoscopic plantar fasciotomy
Number of subjects: 16
Study 15680101 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-athletic patients)
Number of subjects: 16
Study 11444444 — intervention group
Group type: EXPERIMENTAL
Intervention: Mepivacaine + clonidine (Mc)
Number of subjects: 120
Study 11444444 — intervention group
Group type: COMPARATOR
Intervention: Mepivacaine (Mo)
Number of subjects: 120
Study 11444444 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine + clonidine (Rc)
Number of subjects: 120
Study 11444444 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine (Ro)
Number of subjects: 120
Study 11444444 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine + clonidine (Bc)
Number of subjects: 120
Study 11444444 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (Bo)
Number of subjects: 120
Study 9753232 — intervention group
Group type: EXPERIMENTAL
Intervention: rebamipide 100 mg three times a day
Number of subjects: 20
Study 9753232 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study 7844059 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncontingent presentation of food on a fixed-time schedule (e.g., FT 30 s)
Number of subjects: 4